Personalis, Inc. (PSNL) Investor Relations Documents

Personalis, Inc. (PSNL) investor relations documents from the company's IR site: 1 presentation, 36 press releases; latest deck 2026-05-11. Read in-app with summaries. First-party data.

Personalis Investor Presentation: Personalis offers early cancer detection and personalized therapies, projecting $78-80M revenue in 2026 with over 25,000 tests delivered.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-04Press releasePersonalis Reports Second Quarter Results and Recent Highlights
2026-07-14Press releasePersonalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support
2026-06-09Press releasePersonalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
2026-06-02Press releasePersonalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set
2026-05-26Press releasePersonalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podi
2026-05-20Press releasePersonalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgica
2026-05-14Press releasePersonalis to Participate in Upcoming Investor Events
2026-05-13Press releasePersonalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors
2026-05-11PresentationPersonalis Investor Presentation
2026-05-07Press releasePersonalis Reports First Quarter Results and Recent Highlights
Press releaseRead More
Press releasePersonalis to Announce Fourth Quarter and Full Year 2025 Financial Results
Press releasePress Release
Press releaseQ1
2025-02-27Press releaseQ4
2025-02-13Press releasePersonalis to Announce Fourth Quarter and Full Year 2024 Financial Results
2025-01-07Press releasePersonalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue
2024-11-06Press releaseQ3
2024-10-23Press releasePersonalis to Announce Third Quarter 2024 Financial Results
2024-08-07Press releaseQ2
2024-05-08Press releaseQ1
2023-11-07Press releaseQ3
2023-08-08Press releaseQ2
2023-05-03Press releaseQ1
2023-02-23Press releaseQ4
2022-11-02Press releaseQ3
2022-08-03Press releaseQ2
2022-05-04Press releaseQ1
2022-02-24Press releaseQ4
2021-11-04Press releaseQ3
2021-08-04Press releaseQ2
2021-05-05Press releaseQ1
2021-02-25Press releaseQ4
2020-11-05Press releaseQ3
2020-08-06Press releaseQ2
2020-05-07Press releaseQ1
Press releaseQ4

PSNL overview · PSNL earnings · PSNL financials · PSNL KPIs · PSNL documents · PSNL ownership · PSNL peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.